Skip to content
Home/Companies/MedTech/STAT-Diagnostica

STAT-Diagnostica

MedTech·ES·Exited 2018·Held 7yr
Entry
2011
Hold
7yr
Exit
2018

Who owns STAT-Diagnostica?

STAT-Diagnostica was owned by Ysios Capital Partners through Ysios BioFund I (2008 vintage) from 2011 to 2018, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-03

Ysios Capital Partners
Investor
Ysios Capital Partners
Ysios BioFund I · 2008 · Life Sciences VC

Key facts

HQES
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2018

More from Ysios BioFund I

Other portfolio companies in the same fund.

Galecto Biotech
Exited 2020
BiotechDK· 2018
Sanifit
Exited 2021
BiotechES· 2015
to
KALA BIO
Kala BIO
Exited 2017
BiotechUS· 2014
AM Pharma
AM Pharma
Active
BiotechNL· 2011
MedLumics
Active
MedTechES· 2011
BioVex
Exited 2011
BiotechUS· 2009
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track STAT-Diagnostica

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy STAT-Diagnostica?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on STAT-Diagnostica.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue